Spencer Lanoue

Spencer Lanoue is the founder of GLP Index, an independent guide to GLP-1 medications, telehealth providers, and the supplements and tools that support treatment.

Before GLP Index, Spencer spent a decade in growth and content marketing for software companies, where the job was the same as it is here: research a crowded, confusing market until it makes sense, then explain it plainly.

GLP Index takes no money from drugmakers. Where the site earns affiliate commissions from providers, that never changes a recommendation — the editorial policy spells out how.